top of page
DE.jpg

IN THE STATES

DELAWARE

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Delaware in 2022.

DE.png

Economic
Output

$2.8B

Direct Jobs Supported by the Industry

4,267

Total Jobs Supported

8,597

State Total Vendor Relationships

398

State Total Vendor Spending

$238,221,466

Clinical
Trials

68

Investments at Clinical Trial Sites

$7.3M

Clinical Trial Participants

770

Total Economic Impact of Clinical Trial Sites

$18.1M

bottom of page